Androxal
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
245 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Infertility | D007246 | HP_0000789 | — | 9 | 16 | 25 | 40 | 38 | 117 |
| Polycystic ovary syndrome | D011085 | EFO_0000660 | E28.2 | 7 | 13 | 23 | 25 | 33 | 95 |
| Syndrome | D013577 | — | — | 1 | 7 | 12 | 16 | 24 | 58 |
| Anovulation | D000858 | — | — | 1 | 5 | 5 | 6 | 7 | 23 |
| Female infertility | D007247 | EFO_0008560 | N97 | 1 | 3 | 5 | 6 | 8 | 20 |
| Ovulation induction | D010062 | — | — | — | — | 3 | 4 | 2 | 9 |
| Pregnancy | D011247 | EFO_0002950 | Z33.1 | 1 | — | 3 | 2 | 1 | 7 |
| Endometriosis | D004715 | EFO_0001065 | N80 | — | — | — | 1 | 3 | 4 |
| Vitamin d deficiency | D014808 | EFO_0003762 | E55 | 1 | 2 | — | 1 | 1 | 4 |
| Primary ovarian insufficiency | D016649 | EFO_0004266 | E28.3 | — | 2 | — | 1 | — | 3 |
Show 3 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Hypogonadism | D007006 | HP_0000044 | E23.0 | 3 | 13 | 9 | — | 2 | 27 |
| Neoplasm metastasis | D009362 | EFO_0009708 | — | — | 4 | 6 | — | — | 10 |
| Male infertility | D007248 | EFO_0004248 | N46 | — | 2 | 2 | — | 1 | 4 |
| Hyperandrogenism | D017588 | — | — | — | 2 | 1 | — | — | 3 |
| Leiomyoma | D007889 | HP_0000131 | D25 | 1 | — | 1 | — | — | 2 |
| Azoospermia | D053713 | EFO_0000279 | N46.0 | — | — | 1 | — | 1 | 2 |
| Overweight | D050177 | — | E66.3 | — | — | 2 | — | — | 2 |
| Insulin resistance | D007333 | HP_0000855 | — | — | — | 1 | — | — | 1 |
| Spontaneous abortion | D000022 | EFO_1001255 | O00.1 | — | — | 1 | — | — | 1 |
| Gestational diabetes | D016640 | HP_0009800 | O24.4 | — | — | 1 | — | — | 1 |
Show 4 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Eunuchism | D005058 | EFO_0007266 | E29.1 | — | 2 | — | — | 1 | 3 |
| Obesity | D009765 | EFO_0001073 | E66.9 | — | 2 | — | — | — | 2 |
| Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | — | 2 | — | — | — | 2 |
| Endocrine system diseases | D004700 | EFO_0001379 | E34.9 | 1 | 1 | — | — | — | 1 |
| Gonadal disorders | D006058 | — | — | 1 | 1 | — | — | — | 1 |
| Uterine hemorrhage | D014592 | — | — | — | 1 | — | — | — | 1 |
| Hyperprolactinemia | D006966 | HP_0000870 | E22.1 | — | 1 | — | — | — | 1 |
| Opioid-related disorders | D009293 | EFO_0005611 | F11 | — | 1 | — | — | — | 1 |
| Acromegaly | D000172 | — | — | — | 1 | — | — | — | 1 |
| Prostatic neoplasms | D011471 | — | C61 | — | 1 | — | — | — | 1 |
Show 3 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Pregnancy rate | D018873 | — | — | 1 | — | — | — | 2 | 3 |
| Ovarian hyperstimulation syndrome | D016471 | — | — | 1 | — | — | — | 1 | 2 |
| Pharmacokinetics | D010599 | — | — | 2 | — | — | — | — | 2 |
| Substance-related disorders | D019966 | EFO_0003890 | F13 | 1 | — | — | — | — | 1 |
| Healthy volunteers/patients | — | — | — | 1 | — | — | — | — | 1 |
| Drug interactions | D004347 | — | — | 1 | — | — | — | — | 1 |
| Therapeutic equivalency | D013810 | — | — | 1 | — | — | — | — | 1 |
| Renal insufficiency | D051437 | HP_0000083 | N19 | 1 | — | — | — | — | 1 |
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Hyperthermia | D000084462 | — | — | — | — | — | — | 4 | 4 |
| Hyperinsulinism | D006946 | HP_0000842 | E16.1 | — | — | — | — | 2 | 2 |
| Thrombosis | D013927 | — | — | — | — | — | — | 1 | 1 |
| Ectopic pregnancy | D011271 | — | O00 | — | — | — | — | 1 | 1 |
| Hysteroscopy | D015907 | — | — | — | — | — | — | 1 | 1 |
| Asymptomatic diseases | D058070 | — | — | — | — | — | — | 1 | 1 |
| Affect | D000339 | — | — | — | — | — | — | 1 | 1 |
| Colorectal neoplasms | D015179 | — | — | — | — | — | — | 1 | 1 |
| Breast neoplasms | D001943 | EFO_0003869 | C50 | — | — | — | — | 1 | 1 |
| Ovarian neoplasms | D010051 | EFO_0003893 | C56 | — | — | — | — | 1 | 1 |
Show 7 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
No data
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
0 adverse events reported
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use